Literature DB >> 9261188

The effect of nitric oxide release rates on the oxidation of human low density lipoprotein.

S P Goss1, N Hogg, B Kalyanaraman.   

Abstract

1-Substituted diazen-1-ium-1,2-diolates, a class of nitric oxide (. NO) donor compounds that spontaneously release .NO at different rates, were used to investigate the effect of .NO release rate upon the oxidation of low density lipoprotein (LDL). All donor compounds conferred an inhibitory effect upon the oxidation of LDL; however, the effect exhibited a biphasic dependence upon the rate of .NO release. The .NO release rate that maximally inhibited oxidation was dependent upon the rate of oxidation. When LDL was rapidly oxidized by copper(II) sulfate, a faster release rate was more effective. In contrast, when LDL was oxidized slowly by 2,2'-azobis-2-amidinopropane hydrochloride, a slower release rate was most effective. This biphasic relationship between .NO release rate and the duration of inhibition was also demonstrated when LDL oxidation was initiated with 5-amino-3-(4-morpholinyl)-1,2, 3-oxadiazolium, a peroxynitrite generator. We conclude that the antioxidant ability of .NO is dependent not only upon the rate of its release from .NO donors, but also upon the rate of oxidation. This conclusion is supported by a kinetic model of LDL oxidation in the presence of .NO.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261188     DOI: 10.1074/jbc.272.34.21647

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Nitrated lipids: a class of cell-signaling molecules.

Authors:  B Kalyanaraman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-03       Impact factor: 11.205

2.  Nitric oxide transport in an axisymmetric stenosis.

Authors:  Xiao Liu; Yubo Fan; X Yun Xu; Xiaoyan Deng
Journal:  J R Soc Interface       Date:  2012-05-16       Impact factor: 4.118

3.  Inhibition of endogenous nitric oxide in the heart enhances matrix metalloproteinase-2 release.

Authors:  Wenjie Wang; Serena Viappiani; Jolanta Sawicka; Richard Schulz
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 4.  Protection of nitro-fatty acid against kidney diseases.

Authors:  Weidong Wang; Chunling Li; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-30

5.  Kinetic modeling of nitric-oxide-associated reaction network.

Authors:  Teh-Min Hu; William L Hayton; Susan R Mallery
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

6.  Nitroxyl (HNO) reacts with molecular oxygen and forms peroxynitrite at physiological pH. Biological Implications.

Authors:  Renata Smulik; Dawid Dębski; Jacek Zielonka; Bartosz Michałowski; Jan Adamus; Andrzej Marcinek; Balaraman Kalyanaraman; Adam Sikora
Journal:  J Biol Chem       Date:  2014-11-05       Impact factor: 5.157

7.  Nitric oxide consumption through lipid peroxidation in brain cell suspensions and homogenates.

Authors:  Robert G Keynes; Charmaine H Griffiths; Catherine Hall; John Garthwaite
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

8.  Detection and identification of oxidants formed during •NO/O2•⁻ reaction: a multi-well plate CW-EPR spectroscopy combined with HPLC analyses.

Authors:  T Koto; R Michalski; J Zielonka; J Joseph; B Kalyanaraman
Journal:  Free Radic Res       Date:  2014-04

9.  Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition.

Authors:  Semira Galijasevic; Ghassan M Saed; Michael P Diamond; Husam M Abu-Soud
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

10.  Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice.

Authors:  Peter J Kuhlencordt; P Padmapriya; S Rützel; J Schödel; K Hu; A Schäfer; P L Huang; G Ertl; J Bauersachs
Journal:  Atherosclerosis       Date:  2008-04-06       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.